PHARMIX: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMIX
Largest movements
- Cash -€333,307
down €333,307 (-77.0%), from €432,889 to €99,582
mainly Net result for the year (-€475,283) and Investment in fixed assets (net) (-€70,075)
- Stocks and contracts -€194,484
down €194,484 (-45.5%), from €427,436 to €232,952
- Receivables within one year -€112,808
down €112,808 (-66.2%), from €170,410 to €57,602
of which Trade receivables: -€61,005
- Profit (loss) carried forward -€475,448
down €475,448, from €39,476 to -€435,971
- Other debts -€60,066
down €60,066 (-25.0%), from €239,997 to €179,931
- Trade debts -€54,597
down €54,597 (-43.7%), from €124,929 to €70,332
- Short-term financial debts -€39,985
down €39,985 (-99.5%), from €40,189 to €204
- Debts after one year -€20,134
down €20,134 (-3.0%), from €666,525 to €646,390
- Gross operating margin -€848,802
down €848,802, from €478,643 to -€370,159
- Taxes -€58,579
down €58,579 (-93.4%), from €62,720 to €4,142
- Write-downs -€45,306
down €45,306 (-100.0%), from €45,306 to €0
- Depreciation +€5,671
up €5,671 (+9.1%), from €62,280 to €67,951
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,282,060 | €642,132 | -€639,928 | -49.9% |
| Fixed assets | 21/28 | €245,242 | €247,365 | +€2,123 | +0.9% |
| Intangible fixed assets | 21 | €6,240 | €4,475 | -€1,765 | -28.3% |
| Tangible fixed assets | 22/27 | €238,317 | €239,785 | +€1,468 | +0.6% |
| Land and buildings | 22 | €86,870 | €68,984 | -€17,887 | -20.6% |
| Plant, machinery and equipment | 23 | €141,240 | €155,663 | +€14,423 | +10.2% |
| Furniture and vehicles | 24 | €10,206 | €15,138 | +€4,932 | +48.3% |
| Financial fixed assets | 28 | €685 | €3,105 | +€2,420 | +353.3% |
| Current assets | 29/58 | €1,036,819 | €394,768 | -€642,051 | -61.9% |
| Stocks and contracts in progress | 3 | €427,436 | €232,952 | -€194,484 | -45.5% |
| Stocks | 30/36 | €427,436 | €232,952 | -€194,484 | -45.5% |
| Amounts receivable within one year | 40/41 | €170,410 | €57,602 | -€112,808 | -66.2% |
| Trade receivables | 40 | €91,314 | €30,309 | -€61,005 | -66.8% |
| Other amounts receivable | 41 | €79,096 | €27,293 | -€51,803 | -65.5% |
| Cash at bank and in hand | 54/58 | €432,889 | €99,582 | -€333,307 | -77.0% |
| Deferred charges and accrued income | 490/1 | €6,083 | €4,631 | -€1,452 | -23.9% |
| Total equity and liabilities | 10/49 | €1,282,060 | €642,132 | -€639,928 | -49.9% |
| Equity | 10/15 | €126,648 | -€348,800 | -€475,448 | |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €62,171 | €62,171 | = | 0.0% |
| Distributable reserves | 133 | €62,171 | €62,171 | = | 0.0% |
| Profit (loss) carried forward | 14 | €39,476 | -€435,971 | -€475,448 | |
| Amounts payable | 17/49 | €1,155,413 | €990,932 | -€164,480 | -14.2% |
| Amounts payable after more than one year | 17 | €666,525 | €646,390 | -€20,134 | -3.0% |
| Financial debts | 170/4 | €666,525 | €646,390 | -€20,134 | -3.0% |
| Amounts payable within one year | 42/48 | €488,888 | €344,542 | -€144,346 | -29.5% |
| Current portion of amounts payable after more than one year | 42 | €81,052 | €94,075 | +€13,023 | +16.1% |
| Financial debts | 43 | €40,189 | €204 | -€39,985 | -99.5% |
| Credit institutions | 430/8 | €40,189 | €204 | -€39,985 | -99.5% |
| Trade debts | 44 | €124,929 | €70,332 | -€54,597 | -43.7% |
| Suppliers | 440/4 | €124,929 | €70,332 | -€54,597 | -43.7% |
| Taxes, remuneration and social security | 45 | €2,720 | €0 | -€2,720 | -100.0% |
| Taxes | 450/3 | €2,720 | €0 | -€2,720 | -100.0% |
| Other amounts payable | 47/48 | €239,997 | €179,931 | -€60,066 | -25.0% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Non-recurring operating income | 76A | €6,658 | €34,111 | +€27,453 | +412.4% |
| Remuneration, social security and pensions | 62 | - | €0 | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €62,280 | €67,951 | +€5,671 | +9.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €45,306 | €0 | -€45,306 | -100.0% |
| Other operating charges | 640/8 | €9,797 | €9,213 | -€584 | -6.0% |
| Gross operating margin | 9900 | €478,643 | -€370,159 | -€848,802 | |
| Operating profit (loss) | 9901 | €361,259 | -€447,324 | -€808,584 | |
| Financial income | 75/76B | €10 | €442 | +€432 | +4482.9% |
| Recurring financial income | 75 | €10 | €442 | +€432 | +4482.9% |
| Financial charges | 65/66B | €24,121 | €24,259 | +€137 | +0.6% |
| Recurring financial charges | 65 | €24,121 | €24,259 | +€137 | +0.6% |
| Profit (loss) for the period before taxes | 9903 | €337,148 | -€471,141 | -€808,289 | |
| Income taxes | 67/77 | €62,720 | €4,142 | -€58,579 | -93.4% |
| Profit (loss) for the period | 9904 | €274,428 | -€475,283 | -€749,710 | |
| Profit (loss) for the period to be appropriated | 9905 | €274,428 | -€475,283 | -€749,710 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.